Phase II clinical trial testing the safety of a humanised monoclonal antibody anti-CD20 in patients with heart failure with reduced ejection fraction, ICFEr-RITU2: study protocol

por Sánchez-Trujillo, Luis, Jerjes-Sanchez, Carlos, Rodriguez, David, Panneflek, Jathniel, Ortiz-Ledesma, Claudia, Garcia-Rivas, Gerardo, Torre-Amione, Guillermo
Publicado 2019

Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review

por Castillo-Perez, Mauricio, Jerjes-Sanchez, Carlos, Castro-Varela, Alejandra, Paredes-Vazquez, Jose Gildardo, Vazquez-Garza, Eduardo, Ramos-Cazares, Ray Erick, Salinas-Casanova, Jose Alfredo, Molina-Rodriguez, Abigail Montserrat, Martinez-Ibarra, Arturo Adrián, Fabiani, Mario Alejandro, Flores-Sayavedra, Yoezer Z, Guajardo-Lozano, Jaime Alberto, Lopez-de la Garza, Hector, Betancourt-del Campo, Hector, Martinez-Magallanes, Daniela, Panneflek, Jathniel
Publicado 2021